This company seems to have been delisted
Reason: Filed for chapter 11 bankruptcy
Last recorded trade on: March 12, 2024
Source: https://www.fiercebiotech.com/biotech/athersys-files-bankruptcy-sells-assets-healios-wake-roke-cell-therapys-struggles
Reason: Filed for chapter 11 bankruptcy
Last recorded trade on: March 12, 2024
Source: https://www.fiercebiotech.com/biotech/athersys-files-bankruptcy-sells-assets-healios-wake-roke-cell-therapys-struggles
Athersys
ATHX
0,01169 €
Share price
-33.50%
Change (1 day)
-98.97%
Change (1 year)
Categories
Athersys (ATHX) - Net assets
Net assets on the balance sheet as of September 2023 : -€31.51 Million
According to Athersys's latest financial reports the company has -€31.51 Million in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Athersys - Net assets on balance sheet (from 2005 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $-€22.24 Million | -253.84% |
| 2021-12-31 | $€14.45 M | -43.31% |
| 2020-12-31 | $€25.49 M | 22.74% |
| 2019-12-31 | $€20.77 M | -44.88% |
| 2018-12-31 | $€37.68 M | 93.45% |
| 2017-12-31 | $€19.48 M | 83.28% |
| 2016-12-31 | $€10.62 M | -41.07% |
| 2015-12-31 | $€18.03 M | 5% |
| 2014-12-31 | $€17.18 M | 19.7% |
| 2013-12-31 | $€14.35 M | -6.23% |
| 2012-12-31 | $€15.3 M | 172.37% |
| 2011-12-31 | $€5.61 M | -16.99% |
| 2010-12-31 | $€6.77 M | -48.83% |
| 2009-12-31 | $€13.23 M | -41.39% |
| 2008-12-31 | $€22.57 M | -30.79% |
| 2007-12-31 | $€32.62 M | -8423600.2% |
| 2006-12-31 | $-€0.01 Million | -145.88% |
| 2005-12-31 | $€0 M | 14.51% |
| 2004-12-31 | $€0 M | -99.99% |
| 2003-12-31 | $€11.87 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | €5.37 B | -17,154.54% | 🇺🇸 USA |
 Pfizer PFE | €78.45 B | -249,136.96% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | €15.10 B | -48,040.65% | 🇺🇸 USA |
 Moderna
MRNA | €8.71 B | -27,757.65% | 🇺🇸 USA |
 Johnson & Johnson JNJ | €67.61 B | -214,714.64% | 🇺🇸 USA |
 United States Lime & Minerals USLM | €0.46 B | -1,562.31% | 🇺🇸 USA |
 Merck MRK | €41.89 B | -133,085.30% | 🇺🇸 USA |
 Sanofi SNY | €69.69 B | -221,317.20% | 🇫🇷 France |